[Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin]
- PMID: 1478401
[Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin]
Abstract
Previous studies have suggested that treatment of ascites in cirrhotic patients by repeated paracenteses and albumin infusion is fast, effective and safe. In one of these studies including patients with hyponatremia or renal impairment, this treatment was associated with a reduction of duration of hospital stay in comparison with large dose diuretics. The aim of this randomized study was to compare paracentesis with albumin perfusion and low dose diuretics in cirrhotic patients with ascites, but without hyponatremia or renal impairment. Twenty-six patients (group 1) were treated with paracentesis (4 L/day) and 27 patients (group 2) were treated with spironolactone (225 to 300 mg/day), associated with furosemide (40 to 80 mg/day), when inefficient alone. Ascites and peripheric edema disappeared more rapidly in group 1 than in group 2, 8.6 +/- 9.6 vs 13.5 +/- 6.7 days (P = 0.001) and 4.1 +/- 2.6 vs 10.5 +/- 6.5 days (P = 0.001) respectively. During hospitalisation, the incidence of complications was higher in group 2 than in group 1: 56 vs 26% (P = 0.03). Hyponatremia occurred in 30% of patients in group 2 and 4% of patients in group 1 (P = 0.04). The duration of hospital stay was shorter in group 1 (15.0 +/- 10.4 days) than in group 2 (21.0 +/- 11.7 days) (P = 0.007). During follow-up, ascites reappeared in 32% of patients in group 1 and 57% of patients in group 2 (P = 0.09). At 3 months, one patient in group 1 and 2 patients in group 2 developed spontaneous peritonitis whereas survival was similar in both groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.Gastroenterol Clin North Am. 1992 Mar;21(1):237-56. Gastroenterol Clin North Am. 1992. PMID: 1568775 Review.
-
[Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].Rev Med Chil. 1990 Aug;118(8):874-80. Rev Med Chil. 1990. PMID: 2152231 Clinical Trial. Spanish.
-
Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.Dig Liver Dis. 2011 Nov;43(11):881-6. doi: 10.1016/j.dld.2011.06.001. Epub 2011 Jul 8. Dig Liver Dis. 2011. PMID: 21741331 Clinical Trial.
-
Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.N Engl J Med. 1991 Sep 19;325(12):829-35. doi: 10.1056/NEJM199109193251201. N Engl J Med. 1991. PMID: 1875966 Clinical Trial.
-
[Treatment of ascites in liver cirrhosis].Ugeskr Laeger. 1994 Sep 12;156(37):5256-65. Ugeskr Laeger. 1994. PMID: 7941060 Review. Danish.
Cited by
-
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013123. doi: 10.1002/14651858.CD013123.pub2. Cochrane Database Syst Rev. 2020. PMID: 31978257 Free PMC article.
-
Intravenous albumin infusion is an effective therapy for hyponatremia in patient with malignant ascites.Indian J Nephrol. 2014 Jan;24(1):51-3. doi: 10.4103/0971-4065.125116. Indian J Nephrol. 2014. PMID: 24574634 Free PMC article.
-
Efficacy of furosemide for treatment of liver cirrhosis: A systematic review protocol of randomized controlled trial.Medicine (Baltimore). 2019 Apr;98(16):e15300. doi: 10.1097/MD.0000000000015300. Medicine (Baltimore). 2019. PMID: 31008980 Free PMC article.
-
Hepatic disorders. Features and appropriate management.Drugs. 1995 Jan;49(1):83-102. doi: 10.2165/00003495-199549010-00007. Drugs. 1995. PMID: 7705218 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical